MRPL19

Large ribosomal subunit protein bL19m · P49406 · MRPL19 on Sugi Atlas →

0 patent compounds predicted against MRPL19, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to MRPL19 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia PHASE2COMPLETED
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL) PHASE2COMPLETED
Spheroidal Mesenchymal Stem Cells in Retinitis Pigmentosa PHASE1/PHASE2COMPLETED
IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101) PHASE1/PHASE2COMPLETED
Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia PHASE1RECRUITING
Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia PHASE1COMPLETED
Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS) nanRECRUITING
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN nanUNKNOWN
Serum NGAL IN Patients With Multiple Myeloma nanUNKNOWN
Identification of New FTLD Genes nanUNKNOWN
Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Phenotyping of Small Bowel Adenocarcinoma nanCOMPLETED
Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) Probands nanCOMPLETED
Genetic Investigations in Children With Developmental and Epileptic Encephalopathies in Ho Chi Minh City, Vietnam nanUNKNOWN
Amyotrophic Lateral Sclerosis (ALS) Families Project nanRECRUITING
Chromosome 5Q Gene Variants and Asthma-Related Traits nanCOMPLETED
Family Study of Melanoma in Italy nanCOMPLETED
Gene Modifiers of Cystic Fibrosis Lung Disease nanACTIVE_NOT_RECRUITING
Risk Factors for the Development of Celiac Disease in Genetically Predisposed Children nanUNKNOWN
New Strategies of Genetic Study of Patients With Oculocutaneous Albinism nanCOMPLETED
Genetic and Protein Profiling in Normal and Cancerous Breast Tissue nanCOMPLETED
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages nanCOMPLETED
Multi-Dimensional Genomic Dissection of Ring Chromosome 14 Syndrome nanACTIVE_NOT_RECRUITING
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Potential Role of CD9 and Implication of Motility Process in Pathogenesis of TEL/ALM1-positive ALL Relapses (LAL TEL/ALM1 and CD9). nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a MRPL19 binder may also engage these)

ProteinNameSimilarity
Q5R8M4 1.000 Q5R8M4 →
Q9D338 1.000 Q9D338 →
Q9VHN6 0.997 Q9VHN6 →
Q2HJI0 0.997 Q2HJI0 →
Q95Y83 0.989 Q95Y83 →
Q5XI37 0.983 Q5XI37 →
Q9VXB5 0.982 Q9VXB5 →
Q2TBI6 0.982 Q2TBI6 →
MRPS35 Small ribosomal subunit protein mS35 0.982 landscape →
Q9VMX0 0.982 Q9VMX0 →
Q5R7L3 0.981 Q5R7L3 →
Q9VMY1 0.981 Q9VMY1 →
Q7RXU7 0.981 Q7RXU7 →
Q9P015 0.981 Q9P015 →
Q9U6M0 0.981 Q9U6M0 →
Q9NQ50 0.980 Q9NQ50 →
Q68EV6 0.980 Q68EV6 →
Q9CPR5 0.980 Q9CPR5 →
A1A4J7 0.979 A1A4J7 →
Q5ZKT8 0.979 Q5ZKT8 →
Q3ZBX6 0.979 Q3ZBX6 →
Q61733 0.978 Q61733 →
A6SLT9 0.978 A6SLT9 →
A2VD95 0.978 A2VD95 →
Q9ULR0 0.978 Q9ULR0 →
Q4R5K7 0.978 Q4R5K7 →
Q9Y6G3 0.978 Q9Y6G3 →
Q8HXG5 0.978 Q8HXG5 →
Q6DJK9 0.978 Q6DJK9 →
Q61DA8 0.978 Q61DA8 →